Demonstration☀ SUN PHARMA
ILLUSTRATIVE WORKSHOP PREPARATION

From perspectives to decisions.

A lightweight example of how responses can focus the next workshop.

Synthetic sample data. These three fictional responses demonstrate the summary. They are not Sun Pharma findings or recommended mappings.

3RESPONSES IN VIEW
3FUNCTIONS REPRESENTED
1MISSING DELIVERABLES RAISED

Evidence connections

Number of respondents associating each deliverable with a critical question. Denominator: 3 responses in this view.

Counts of selected connections by question and deliverable
Critical questionD1D2D3D4D5
Q1 · Patient population3 / 30 / 30 / 30 / 31 / 3
Q2 · Priority segments3 / 33 / 30 / 30 / 30 / 3
Q3 · Competitive context0 / 30 / 33 / 33 / 31 / 3
Q4 · Assumptions & uncertainty3 / 30 / 33 / 33 / 33 / 3

D1: Patient population & market sizing · D2: Market segmentation · D3: Competitive landscape · D4: Product profile & differentiation · D5: Market access landscape

Ownership perspectives

Functions reporting a lead/accountable role. Multiple claims are prompts for discussion.

  • D1 · Patient population & market sizing: MI&A
  • D2 · Market segmentation: MI&A
  • D3 · Competitive landscape: MI&A
  • D4 · Product profile & differentiation: Clinical Development
  • D5 · Market access landscape: Market Access

Open questions for the workshop

Missing · MI&A · Q4: Scenario-based opportunity sensitivity model. Make upside/downside scenarios and their assumptions explicit.

Conditional · Market Access · D5: Depth should reflect payer restrictions and reimbursement complexity for the launch.

Dependency · Clinical Development: Clinical label assumptions must be agreed before the addressable population is finalized.

Read every connection in the context of function and expertise. A low selection count does not make a deliverable unnecessary. These counts identify questions to explore; they do not establish consensus or approved ownership.

Return to survey